Cargando…
Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups
SIMPLE SUMMARY: Angiosarcomas (AS) are rare and aggressive soft tissue sarcomas that can be subdivided in de novo primary AS and secondary AS. They have a very poor prognosis and only limited treatment options are available. Immunotherapy is not registered as treatment for AS. Characterization of th...
Autores principales: | van Ravensteijn, Stefan G., Versleijen-Jonkers, Yvonne M. H., Hillebrandt-Roeffen, Melissa H. S., Weidema, Marije E., Nederkoorn, Maikel J. L., Bol, Kalijn F., Gorris, Mark A. J., Verrijp, Kiek, Kroeze, Leonie I., de Bitter, Tessa J. J., de Voer, Richarda M., Flucke, Uta E., Desar, Ingrid M. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739001/ https://www.ncbi.nlm.nih.gov/pubmed/36497420 http://dx.doi.org/10.3390/cancers14235938 |
Ejemplares similares
-
Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5)
por: Versleijen-Jonkers, Yvonne M. H., et al.
Publicado: (2023) -
Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups
por: Tomassen, T., et al.
Publicado: (2022) -
PARP inhibition in UV-associated angiosarcoma preclinical models
por: Weidema, Marije E., et al.
Publicado: (2021) -
Prognostic Factors in a Large Nationwide Cohort of Histologically Confirmed Primary and Secondary Angiosarcomas
por: Weidema, Marije E., et al.
Publicado: (2019) -
Prognostic Factors in Epithelioid Hemangioendothelioma: Analysis of a Nationwide Molecularly/Immunohistochemically Confirmed Cohort of 57 Cases
por: Tomassen, Tess, et al.
Publicado: (2023)